CannaPharmaRx CEO Provides Annual Update Message
Dear Fellow Shareholders, We are paving the way for a remarkable year capitalizing on the solid foundation achieved last year. 2023 was an exciting and pivotal year for
CannaPharmaRx Expands Board of Directors
CannaPharmaRx, Inc. (OTC EXPERT: CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has expanded its Board of
CannaPharmaRx Appoints Dean Medwid as New CEO
CannaPharmaRx, Inc. (OTC PINK: CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that the company has appointed a new
Terms & Conditions
The following TERMS & CONDITIONS (“Terms & Conditions”) are a legal and binding agreement between you and CannapharmaRx (“CannapharmaRx,” “we,” “our”, or “us”), g
CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities today released a letter from its Chief Executive Offi
Financials
Quarterly Report 2022 Annual Report Third Quarter (Q3) Second Quarter (Q2) 2021 First Quarter (Q1) 2020